First-Generation Macrolide — Penicillin Allergy Alternative / Gastroparesis Prokinetic
Pregnancy: Safe (except estolate formulation) — erythromycin widely used in pregnancy; azithromycin preferred for macrolide atypical cover
Erythromycin
Brand names: Erythrocin, Erythroped, Tiloryth
Adult dose
Dose: Infection: 250–500 mg every 6 hours orally; IV: 6.25–12.5 mg/kg every 6 hours; Gastroparesis (prokinetic): 250 mg 3–4 times daily before meals
Route: Oral or IV
Frequency: 4 times daily
Max: 4 g/day
Oldest macrolide — fewer interactions than clarithromycin. Used as penicillin allergy alternative for respiratory infections, skin infections, STIs (chlamydia), pertussis. As prokinetic: stimulates motilin receptors in GI tract — accelerates gastric emptying. IV formulation causes significant phlebitis — central line preferred for IV use.
Paediatric dose
Dose: 12.5 mg/kg mg/kg
Route: Oral
Frequency: 4 times daily
Max: 2 g/day
BNFc: suspension available (125, 250, 500 mg/5 mL); used for pertussis, chlamydia conjunctivitis in neonates, penicillin allergy
Dose adjustments
Renal
No dose adjustment required
Hepatic
Use with caution — hepatically metabolised; cholestatic jaundice risk (erythromycin estolate formulation — avoid in hepatic impairment)
Paediatric weight-based calculator
BNFc: suspension available (125, 250, 500 mg/5 mL); used for pertussis, chlamydia conjunctivitis in neonates, penicillin allergy
Clinical pearls
- Prokinetic use: well-established for gastroparesis (especially diabetic) and ICU gastric emptying — mechanism distinct from metoclopramide (motilin agonist not dopamine antagonist); tachyphylaxis develops within days — often used for short periods
- GI side effects are the major limitation — nausea/vomiting in up to 50% of patients; azithromycin or clarithromycin preferred when available
- Pertussis: erythromycin (or azithromycin) for 7–14 days — reduces infectivity even if does not alter course once cough established; give to household contacts
- Phlebitis with IV: dilute to <1 mg/mL and use large vein or central line
Contraindications
- Concurrent cisapride, pimozide, or ergotamine
- QT prolongation
- Erythromycin estolate in hepatic impairment
Side effects
- GI upset (nausea, vomiting, diarrhoea — very common)
- QTc prolongation
- Cholestatic jaundice (especially estolate form)
- Phlebitis (IV)
- Hearing loss (high doses)
- Dysgeusia
Interactions
- Warfarin — enhanced anticoagulant effect
- Statins (simvastatin) — increased statin levels
- Digoxin — increased levels
- Carbamazepine — increased levels
- Theophylline — reduced clearance (toxicity)
- Colchicine — toxicity (less potent CYP3A4 inhibitor than clarithromycin)
Monitoring
- ECG (QTc)
- LFTs (cholestatic jaundice)
- Hearing (high-dose/prolonged courses)
- Theophylline levels if co-prescribed
Reference: BNFc; BNF 90; PHE Antibiotic Guidelines; NICE Pertussis Guidance; MHRA QT Prolongation Guidance. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Steinhart Model for Acute Heart Failure in Undifferentiated Dyspnoea · Heart Failure
- FOUR Score (Full Outline of UnResponsiveness) · Consciousness
- Centor/McIsaac Score (Pharyngitis) · Throat Infections
- First Unprovoked Seizure — Recurrence Risk · Epilepsy
- Epilepsy Risk after First Seizure (MESS Score) · Epilepsy
Pathways